Karin Knobe (Former)
1 – 15 of 26
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Evaluation of prophylactic therapy in haemophilia with global coagulation tests
(
- Contribution to journal › Letter
- 2017
-
Mark
Comparative burden of arthropathy in mild haemophilia : a register-based study in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
Lupus anticoagulants in two children-bleeding due to nonphospholipid-dependent antiprothrombin antibodies.
(
- Contribution to journal › Article
-
Mark
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
(
- Contribution to journal › Article
-
Mark
New treatments in hemophilia: insights for the clinician.
(
- Contribution to journal › Article
-
Mark
How to manage invasive procedures in children with haemophilia.
(
- Contribution to journal › Article
-
Mark
Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
(
- Contribution to journal › Article
- 2011
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
-
Mark
Ovanliga ärftliga former av blödarsjuka. Blödningssymtom, familjehistoria och laboratorieanalyser ger diagnosen.
(
- Contribution to journal › Article
-
Mark
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
(
- Contribution to journal › Article
- 2010
-
Mark
Hemophilia A patients without detectable mutations - investigation of disease-associated factors
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Female haemophilia A caused by skewed X inactivation
(
- Contribution to journal › Letter
-
Mark
Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?
(
- Contribution to journal › Article
- 2006
-
Mark
Functional Analysis of the Factor IX Epidermal Growth Factor-Like Domain Mutation Ile66Thr Associated with Mild Hemophilia B.
(
- Contribution to journal › Article